|drug633||COVID-19 Convalescent Plasma (CCP) Wiki||1.00|
There is one clinical trial.
This study will examine the productivity of the hospital workforce utilizing a unique dataset that is stored at the Royal Wolverhampton Trust (RWT). The data is recorded by a Real Time Location System (RTLS) that tracks the second-by-second physical location of patients, staff, and medical equipment. Using this data, the plan is to measure the amount of time that clinical staff spend with patients and with other clinical staff, and then explore how these measures of contact time influence patient health outcomes. The data will also be used to measure the location and movement of patients during their hospital stay, and test the impact of moving patients between wards on their health outcomes. In light of the recent COVID-19 outbreak, impact of COVID19 on patient contact time, patient outcomes and professional working practices will also be examined.
Description: in-hospital mortality figuresMeasure: Number of in-hospital deaths (RWT specific) Time: 30 days
Description: readmission figuresMeasure: Number of readmissions (RWT specific) Time: 30 days
Description: total amount of time in hospitalMeasure: Length of stay Time: 3 years
Description: Number of Falls, medication errors, pressure ulcers and Urinary Tract InfectionsMeasure: Nurse sensitive indicators Time: 3 years
Description: Number and description of Adverse incidents affecting patient care as recorded by the Datix information system (e.g. falls, medication errors)Measure: Number of Adverse incidents affecting patient care Time: 3 years
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports